趙怡翔的〈紐約時報〉 Prices Will Vary 價格變化很大

【縛雞之論】英文拷到 G / D 找中文翻譯
趙怡翔引用的〈紐約時報〉畫面摘要，原來是實況的敘述，不是贊同契約保密。
趙怡翔的英文，不會只是這樣而已吧？或者，他的FB也是「內容農場」供稿？

Prices Will Vary  價格變化很大

One of the key terms of the vaccine contracts — the price per dose — is frequently redacted in the public versions of government contracts. The companies consider this a trade secret. Some drug companies have included clauses in their supply contracts that allow them to suspend deliveries if countries reveal the price.

By insisting that their pricing remains confidential, the drug makers have the upper hand over government negotiators who do not know what other countries are paying.  疫苗契約的關鍵條款之一——每劑的價格——經常在政府契約的公開版本中被修改。這些公司認為這是商業秘密。一些製藥公司在其供應契約中包含條款，讓他們得在各國披露價格時暫停供貨。

通過堅持對他們的定價保密，製藥商在不知道其他國家支付什麼費用的政府談判者面前佔了上風。

While governments accepted that provision, leaks and some official reports show some of the disparities. The European Commission paid $2.19 for every dose of the vaccine developed by the University of Oxford and AstraZeneca, while South Africa paid more than twice as much, $5.25, according to media reports. 雖然政府接受了這一規定，但洩密和一些官方報告顯示了一些差異。 據媒體報導，歐盟委員會為牛津大學和阿斯利康開發的每劑疫苗支付了 2.19 美元，而南非支付了 5.25 美元的兩倍多。

Drug companies did not respond to requests to view their unredacted contracts or explain why secrecy was necessary. A spokeswoman for Moderna pointed only to a regulatory document that said the contract “contains terms and conditions that are customary.” 製藥公司沒有回應查看其未經編輯的合同或解釋為什麼需要保密的請求。 Moderna 的一位女發言人只指出了一份監管文件，該文件稱合同“包含慣例的條款和條件”。

That is why it caused such a stir last month when a Belgian official mistakenly revealed a price list, which showed that United States taxpayers were paying $19.50 per dose for the Pfizer vaccine, while Europeans paid $14.70. 這就是為什麼上個月比利時官員錯誤地披露了一份價目表，顯示美國納稅人為輝瑞疫苗每劑支付 19.50 美元，而歐洲人支付 14.70 美元時，引起瞭如此大的轟動。

Dag Inge Ulstein, Norway’s minister of international development, said countries and international organizations must do more to make contracts public. He also called on countries to share vaccine technology and said rich governments should donate vaccines to poor countries early — even while still vaccinating their own citizens, as Norway plans to do. 挪威國際發展部長 Dag Inge Ulstein 表示，各國和國際組織必須採取更多措施將契約公之於眾。 他還呼籲各國分享疫苗技術，並表示富國政府應儘早向窮國捐贈疫苗——即使仍在為本國公民接種疫苗的同時，挪威也計劃這樣做。

“There must be transparency related to the agreements on procurements,” he said in an interview. To that end, he shared with The New York Times his country’s purchase agreement with Covax. That organization has refused to make public its deals — either with the drug makers or with the countries it is selling to. “採購協議必須具有透明度，”他在接受採訪時說。 為此，他與《紐約時報》分享了他所在國家與 Covax 的採購協議。 該組織拒絕公開其交易——無論是與製藥商還是與它所銷售的國家。

Covax contracts with countries assume a cost of $10.55 per dose but warn that the final cost could be higher after including an “access/speed premium,” which Covax said is used to help companies rush their vaccines to market. Covax 與各國簽訂的契約假設每劑成本為 10.55 美元，但警告稱，在包括“訪問/速度溢價”後，最終成本可能會更高，Covax 稱該溢價用於幫助公司將疫苗推向市場。

 

 

Governments Sign Secret Vaccine Deals. Here’s What They Hide.